| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,340,000 |
| Market
Cap: |
412.28(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.48 - $24.56 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 9.9 |
| Insider 6 Months : 9.9 |
| Insider 3/6 Months : 20.2 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pulse Biosciences is a bioelectric medicine company. The CellFX® System (CellFX) is the commercial product to harness the distinctive advantages of Co.'s proprietary Nano-Pulse Stimulation™ (NPS) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of conditions for which an optimal solution remains unfulfilled. The CellFX System is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. Co. has also designed an integrated cloud software infrastructure called CellFX CloudConnect™. CellFX CloudConnect also facilitates direct connectivity to the CellFX System.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
34,659 |
34,659 |
191,373 |
1,419,747 |
| Total Buy Value |
$508,101 |
$508,101 |
$3,207,514 |
$15,259,653 |
| Total People Bought |
1 |
1 |
1 |
4 |
| Total Buy Transactions |
1 |
1 |
4 |
23 |
| Total Shares Sold |
75,000 |
105,000 |
155,000 |
155,000 |
| Total Sell Value |
$1,121,750 |
$1,607,450 |
$2,478,450 |
$2,478,450 |
| Total People Sold |
1 |
1 |
2 |
2 |
| Total Sell Transactions |
3 |
5 |
6 |
6 |
| End Date |
2025-06-19 |
2025-03-18 |
2024-09-17 |
2023-09-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-15 |
4 |
AS |
$15.77 |
$394,250 |
D/D |
(25,000) |
122,872 |
|
- |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-15 |
4 |
OE |
$4.00 |
$100,000 |
D/D |
25,000 |
147,872 |
|
- |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-12 |
4 |
AS |
$14.32 |
$358,000 |
D/D |
(25,000) |
122,872 |
|
- |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-12 |
4 |
OE |
$4.00 |
$100,000 |
D/D |
25,000 |
147,872 |
|
- |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-11 |
4 |
AS |
$14.78 |
$369,500 |
D/D |
(25,000) |
122,872 |
|
- |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-09-11 |
4 |
OE |
$4.00 |
$100,000 |
D/D |
25,000 |
147,872 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2025-09-10 |
4 |
B |
$14.66 |
$508,101 |
D/D |
34,659 |
47,551,200 |
3.92 |
10% |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-06-13 |
4 |
S |
$15.98 |
$239,700 |
D/D |
(15,000) |
122,872 |
|
-3% |
|
| Uecker Darrin |
Chief Technology Officer |
• • – |
2025-06-12 |
4 |
S |
$16.40 |
$246,000 |
D/D |
(15,000) |
137,872 |
|
-1% |
|
| Zanganeh Maky |
Director |
• • – |
2025-02-03 |
4 |
OE |
$11.00 |
$331,331 |
D/D |
30,121 |
725,395 |
|
- |
|
| Zanganeh Maky |
Director |
• • – |
2025-01-24 |
4 |
OE |
$11.00 |
$331,331 |
D/D |
30,121 |
695,274 |
|
- |
|
| Duggan Robert W |
|
– • • |
2024-12-18 |
4 |
OE |
$11.00 |
$1,301,652 |
I/I |
118,332 |
450,189 |
|
- |
|
| Duggan Robert W |
|
– • • |
2024-12-18 |
4 |
OE |
$11.00 |
$57,066,064 |
D/D |
5,187,824 |
47,516,541 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-12-13 |
4 |
B |
$17.18 |
$949,298 |
D/D |
55,256 |
42,328,717 |
3.92 |
2% |
|
| Duggan Robert W |
|
– • • |
2024-12-12 |
4 |
B |
$17.13 |
$777,771 |
D/D |
45,404 |
42,273,461 |
0.01 |
4% |
|
| Barrett Burke Thomas |
Former President and CEO |
• • – |
2024-12-11 |
4 |
S |
$17.42 |
$871,000 |
D/D |
(50,000) |
63,172 |
|
-12% |
|
| Duggan Robert W |
Director |
• • • |
2024-12-11 |
4 |
B |
$16.74 |
$972,344 |
D/D |
56,054 |
42,228,057 |
3.92 |
12% |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2024-09-24 |
4 |
OE |
$11.00 |
$24,266 |
I/I |
2,206 |
8,521 |
|
- |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2024-09-24 |
4 |
OE |
$11.00 |
$33,000 |
D/D |
3,000 |
93,880 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-09-12 |
4 |
B |
$14.41 |
$2,091,467 |
D/D |
145,140 |
47,709,140 |
3.92 |
-6% |
|
| Duggan Robert W |
Director |
• • • |
2024-09-11 |
4 |
B |
$14.77 |
$189,056 |
D/D |
12,800 |
47,564,000 |
3.92 |
9% |
|
| Barrett Burke Thomas |
President and CEO |
• • – |
2024-07-19 |
4 |
OE |
$11.00 |
$11,946 |
D/D |
1,086 |
12,172 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
118,332 |
400,877 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,187,824 |
42,172,003 |
|
- |
|
| Zanganeh Maky |
Director |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,242 |
665,153 |
|
- |
|
158 Records found
|
|
Page 1 of 7 |
|
|
0.37 (2.22%) 
